CLINICAL RESEARCH & DIAGNOSTICS Clinical Trials Update news from GENLatest news on the progress of drug candidates through the different phases of clinical trials. Tuesday, February 09, 2010http://www.genengnews.com/news/newslist.aspx?taxid=26 Cancer Research UK to Fund Clinical Trial of ADXS11-001 for the Treatment of Head and Neck Cancer Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75135916 AspenBio Pharma Reports on AppyScore(TM) Supplemental Clinical Trial Interim Analysis and Provides Guidance on FDA 510(k) Filing Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75140122 BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75124264 Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75113322 Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75083328 Obese teens who receive gastric banding achieve significant weight loss Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75141304 Molecular pathways linked to sex, age affect outcomes in lung cancer Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75141306 Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer Tuesday, February 09, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75140126 Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75071402 Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM) Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75055095 Vitrolife: Patient Recruitment to the Clinical Study on STEEN Solution™ is Now Complete Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75031482 Kamada Announces Enrollment of First Patient in Its Pivotal Study for Inhaled AAT in Europe Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75029065 Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanoma Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75026629 New Research Quantifies Drivers of Participation in Clinical Trials and Finds that Trial Awareness Stunts Participation Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75026633 Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AML Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75023035 Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75021841 Repros Submits Response to FDA Regarding Androxal® Indication for Treatment of Hypogonadal Men Wishing to Preserve Fertility Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75019445 SciClone and Sigma-Tau Announce Additional Positive Results in Clinical Study Examining ZADAXIN's Ability to Enhance Response to H1N1 Vaccine Monday, February 08, 2010 http://www.genengnews.com/news/bnitem.aspx?name=75017753